Health Economics/Outcomes Research, Health Policy, Pharmacoeconomics/Health Economics
Postdoctoral Fellowship in the Health Sciences
Collaboration for Outcomes Research and Evaluation (CORE),
Faculty of Pharmaceutical Sciences
EXPLAIN-yCRC is a project funded by Canadian Institute of Health Research that is led by Dr. Mary De Vera. The project involves linkage of British Columbia’s rich data resources including a population-based cancer registry and administrative health databases on outpatient visits, hospitalizations, vital statistics, and all prescriptions to conduct epidemiologic, health services research, and health economic studies to generate urgently needed knowledge on the growing problem of young-onset colorectal cancer (yCRC).
The EXPLAIN-yCRC team is seeking a Post-Doctoral Fellow for a 2-year term to conduct Health Services Research components of the project which include:
Characterizing the treatment of yCRC in terms of patterns and determinants
Estimating health care costs associated with yCRC
Applicants must have:
A PhD in epidemiology, health services research, health economics, health policy, or a related discipline;
Demonstrated scientific productivity in terms of published manuscripts and conference abstracts;
Experience with analyzing of large databases (preferably using SAS);
A desire to take on leadership responsibilities by leading the development of specific research initiatives within the scope of the broader project.
The Fellow will be primarily appointed at UBC’s Faculty of Pharmaceutical Sciences (https://pharmsci.ubc.ca) with the Collaboration for Outcomes Research and Evaluation (https://core.ubc.ca/). This Fellowship will enable leadership opportunities for the right candidate, and may allow for the development of new research methods and techniques related to the project to be spearheaded by the Fellow. In addition, the Fellow will have a unique opportunity to be mentored by, and collaborate with, leading researchers and healthcare providers at the University of British Columbia and research team members across Canada. This position is best suited to an individual who can work independently and as part of a team, and provide supervision and/or mentorship to research trainees.
Applications will be accepted until the position is filled.
Preferred start date is January 15th, 2019 but is negotiable. Interested and qualified applicants should send a cover letter describing relevant research experience, most significant research accomplishments and a statement of research interests, a curriculum vitae, PDFs of up to three representative publications, and contact information for three referees.
Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority.
About University of British Columbia, Faculty of Pharmaceutical Sciences
Housed within The University of British Columbia’s Faculty of Pharmaceutical Sciences, the Collaboration for Outcomes Research and Evaluation (CORE) is an academic research group established in 2000 by Dr. David Fielding. In 2004, leadership of the research group came under the direction of Dr. Carlo Marra, and Dr. Larry Lynd, with Dr. Lynd appointed as Director in 2014.
The mission of CORE is to improve health?care related outcomes for drug therapy through the application of the best in research, education and practice enhancement strategies. CORE strives to provide evidence which will maximize the clinical, quality of life, and economic benefits of drug therapy, while minimizing associated risks. This is achieved through in dependent research and research collaborations with pharmaceutical and health outcomes researchers throughout North America and Europe.